Browsing by Title

Showing results 41 to 60 of 21018 < previous   next >
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC6210720112020 - 2030 - 2050 - Common Vision of the European Technology Platform on Renewable Heating and CoolingJAEGER-WALDAU Arnulf
JRC9607420152020 Common Agricultural Policy in Spain. General Equilibrium Effects of a EU28 Budget DealBOULANGER PIERRE; PHILIPPIDIS George
JRC10617720172030 European agricultural policy: A new CAP at a crossroad between market competitiveness and sustainabilityBOULANGER PIERRE; DUDU HASAN; FERRARI EMANUELE; M'BAREK ROBERT; PHILIPPIDIS GEORGE
JRC355152006207Pb (n,2ngamma)206Pb Cross-Section Measurements by In-Beam Gamma-Ray SpectroscopyBAUMANN P; BORCEA Catalin; JERICHA E.; JOKIC S.; KERVENO M.; LUKIC S.; MIHAILESCU Liviu; PAVLIK A.; PLOMPEN ARJAN; RUDOLF G.
JRC343072005The 209Bi(nth, )210Bi and 209Bi(nth, )210m,gBi Cross Sections Determined at the Budapest Neutron CentreBORELLA ALESSANDRO; SCHILLEBEECKX PETER; MOLNAR G.l.; BELGYA Tamas; REVAY Zs.; SZENTMIKLOSI Laszlo; BERTHOUMIEUX Eric; GUNSING Frank; LETOURNEAU A.; MARIE F.
JRC827922013213-Bismuth-labeled antibody to gp41 glycoprotein kills ART-treated lymphocytes from HIV patients and HIV-infected monocytes in human blood brain barrier modelMCFARREN A; TSUKROV D; EUGENIN E; LOPEZ L; WILLIAMS D; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; ZOLLA-PAZNER S.; GORNY M.k.; Casadevall Arturo, et al
JRC457082008213Bi (Alpha-emitter)-Antibody Targeting of Breast Cancer Metastases in the neu-N Transgenic Mouse ModelSONG H.; SHAHVERDI K.; HUSO D. L.; ESAIAS C.; FOX J.; LIEDY A.; ZHANG Z.; REILLY R. T.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED, et al
JRC655352013213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple MyelomaCHEREL M.; GOUARD S.; GASCHET J; SAÏ-MAUREL C; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BOURGEOIS N.; GESTIN J.-f.; KRAEBER BODÉRÉ F; BARBET J, et al
JRC831802014213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsPICKHARD Anja; PIONTEK Guido; SEIDL C.; KOPPING Samuel; BLECHERT B.; MISSLBECK Martin; BROCKHOFF Gero; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC718162014213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experienceKRATOCHWIL Clemens; GIESEL Frederik; BRUCHERTSEIFER Frank; MIER Walter; APOSTOLIDIS Christos; BOLL Rose; MURPHY Karen; HABERKORN Uwe; MORGENSTERN Alfred
JRC382252007213bi-Induced Death of Hsc45-M2 Gastric Cancer Cells Is Characterized by G2 Arrest and Up-Regulation of Genes Known to Prevent Apoptosis but Induce Necrosis and Mitotic CatastrpopheSEIDL C.; PORT M.; GILBERTZ K.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER M.; ROEPER B.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M.
JRC990962017213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer XenograftsNONNEKENS J; CHATALIC K.l.s.; MOLKENBOER- KUENEN Jannike; BEERENS Cecile; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; VELDHOVEN-ZWEISTRA Joke; SCHOTTELIUS Margret; WESTER Hans-Jürgen; VAN GENT D, et al
JRC1003462016213Bi-labeled PSMA-targeting agents for alpha radionuclide therapy of prostate cancerCHATALIC K.l.s.; NONNEKENS J; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SCHOTTELIUS Margret; WESTER Hans-Jürgen; VAN WEERDEN W.m.; BOERMAN Otto; DE JONG Marion; HESKAMP Sandra
JRC419502007213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.
JRC981742015223Ra-NaA-silane-PEG-SP(5-11) radiobioconjugate as a new potential radiopharmaceutical for targeted α therapy of glioblastoma multiformeMAJKOWSKA PILIP Agnieszka; KOZMINSKI P; PIOTROWSKA A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BONELLI Milton; LAURENZA Marta; BILEWICZ Aleksander
JRC808892013225Ac and 213Bi alpha-Particle-Emitter Therapy in Combination with SAHA and 17-AAGSENTHAMIZHCHELVAN Srinivasan; SONG H.; MORGENSTERN Alfred; SGOUROS G.
JRC886672014225Ac imaging of NK1-targeted α-particle for glioblastoma radiotherapyABOU Diane; GUERRERO-CAZARES H; MINN Il; POMPER Martin; QUINONES-HINOJOSA Alfredo; MORGENSTERN Alfred; BACK Tom; HOBBS Robert F.; WAHL Richard; SGOUROS George
JRC1061392017225Ac-DOTA-Substance P as a potential radiopharmaceutical for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; MORGENSTERN ALFRED
JRC1013162016225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate CancerKRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; WEIS Mirjam; VERBURG Frederik Anton; MOTTAGHY F; KOPKA Klaus; APOSTOLIDIS CHRISTOS; HABERKORN Uwe; MORGENSTERN Alfred
JRC1061482017225Ac-PSMA617: PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFRED